Literature DB >> 26432947

Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls.

Eleonora Passeri1, Lorraine Jones-Brando2, Claudia Bordón2, Srona Sengupta1, Ashley M Wilson1, Amedeo Primerano1, Judith L Rapoport3, Koko Ishizuka1, Shin-ichi Kano1, Robert H Yolken4, Akira Sawa5.   

Abstract

Toxoplasma gondii is a protozoan parasite capable of establishing persistent infection within the brain. Serological studies in humans have linked exposure to Toxoplasma to neuropsychiatric disorders. However, serological studies have not elucidated the related molecular mechanisms within neuronal cells. To address this question, we used human induced neuronal cells derived from peripheral fibroblasts of healthy individuals and patients with genetically-defined brain disorders (i.e. childhood-onset schizophrenia with disease-associated copy number variations). Parasite infection was characterized by differential detection of tachyzoites and tissue cysts in induced neuronal cells. This approach may aid study of molecular mechanisms underlying individual predisposition to Toxoplasma infection linked to neuropathology of brain disorders.
Copyright © 2015 Institut Pasteur. All rights reserved.

Entities:  

Keywords:  Brain disorders; Cysts; Induced neuronal cells; Schizophrenia; Tachyzoites; Toxoplasma gondii

Mesh:

Year:  2015        PMID: 26432947      PMCID: PMC4758902          DOI: 10.1016/j.micinf.2015.09.023

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  30 in total

1.  Could Toxoplasma gondii have any role in Alzheimer disease?

Authors:  Ozge Yilmaz Kusbeci; Ozlem Miman; Mehmet Yaman; Orhan Cem Aktepe; Suleyman Yazar
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

2.  TOXOPLASMA AND OBLIGATE INTRACELLULAR PARASITISM.

Authors:  A B Sabin; P K Olitsky
Journal:  Science       Date:  1937-04-02       Impact factor: 47.728

3.  Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons.

Authors:  T Yoshimizu; J Q Pan; A E Mungenast; J M Madison; S Su; J Ketterman; D Ongur; D McPhie; B Cohen; R Perlis; L-H Tsai
Journal:  Mol Psychiatry       Date:  2015-01-27       Impact factor: 15.992

4.  Cyst formation by Toxoplasma gondii (RH strain) in vitro. The role of immunologic mechanisms.

Authors:  K Shimada; G R O'Connor; C Yoneda
Journal:  Arch Ophthalmol       Date:  1974-12

5.  Meta-Analysis of Anti-Toxoplasma gondii IgM Antibodies in Acute Psychosis.

Authors:  Joel M Monroe; Peter F Buckley; Brian J Miller
Journal:  Schizophr Bull       Date:  2014-11-09       Impact factor: 9.306

6.  Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder.

Authors:  Emily G Severance; Kristin L Gressitt; Shuojia Yang; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Faith B Dickerson; Robert H Yolken
Journal:  Bipolar Disord       Date:  2013-12-06       Impact factor: 6.744

7.  Antibodies to Toxoplasma gondii in individuals with mania.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Emily Katsafanas; Sunil Khushalani; Robert Yolken
Journal:  Bipolar Disord       Date:  2013-09-18       Impact factor: 6.744

8.  Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Lucy Schweinfurth; Christina Savage; Sunil Khushalani; Robert Yolken
Journal:  J Nerv Ment Dis       Date:  2014-08       Impact factor: 2.254

9.  Exposure to prenatal infection and risk of schizophrenia.

Authors:  Alan S Brown
Journal:  Front Psychiatry       Date:  2011-11-23       Impact factor: 4.157

Review 10.  Toxoplasma gondii and schizophrenia.

Authors:  E Fuller Torrey; Robert H Yolken
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

View more
  6 in total

Review 1.  Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned?

Authors:  Janelle Drouin-Ouellet; Karolina Pircs; Roger A Barker; Johan Jakobsson; Malin Parmar
Journal:  Front Neurosci       Date:  2017-09-28       Impact factor: 4.677

2.  Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study.

Authors:  Noriaki Sagata; Takahiro A Kato; Shin-Ichi Kano; Masahiro Ohgidani; Norihiro Shimokawa; Mina Sato-Kasai; Kohei Hayakawa; Nobuki Kuwano; Ashley M Wilson; Koko Ishizuka; Shiori Kato; Takeshi Nakahara; Makiko Nakahara-Kido; Daiki Setoyama; Yasunari Sakai; Shouichi Ohga; Masutaka Furue; Akira Sawa; Shigenobu Kanba
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

Review 3.  Use of Human Neurons Derived via Cellular Reprogramming Methods to Study Host-Parasite Interactions of Toxoplasma gondii in Neurons.

Authors:  Sandra K Halonen
Journal:  Cells       Date:  2017-09-23       Impact factor: 6.600

Review 4.  Unexpected encounter of the parasitic kind.

Authors:  Holly Matthews; Florian Noulin
Journal:  World J Stem Cells       Date:  2019-11-26       Impact factor: 5.326

5.  Forskolin rapidly enhances neuron-like morphological change of directly induced-neuronal cells from neurofibromatosis type 1 patients.

Authors:  Noriaki Sagata; Shin-Ichi Kano; Masahiro Ohgidani; Shogo Inamine; Yasunari Sakai; Hiroki Kato; Keiji Masuda; Takeshi Nakahara; Makiko Nakahara-Kido; Shouichi Ohga; Masutaka Furue; Akira Sawa; Shigenobu Kanba; Takahiro A Kato
Journal:  Neuropsychopharmacol Rep       Date:  2020-10-10

6.  Depletion of Intracellular Glutamine Pools Triggers Toxoplasma gondii Stage Conversion in Human Glutamatergic Neurons.

Authors:  Hironori Bando; Yasuhiro Fukuda; Nina Watanabe; Jeje Temitope Olawale; Kentaro Kato
Journal:  Front Cell Infect Microbiol       Date:  2022-01-13       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.